Find a Doctor

Find a Doctor
Find any physician affiliated with Lenox Hill Hospital.

Awards & Accolades

Best Doctors 2011

Best Doctors 2011

New York Magazine

Read more
Best Doctors 2010

Best Doctors 2010

New York Magazine

Read more
America's Best Hospitals 2009-10

America’s Best Hospitals 2009-10

U.S. News and World Report

Read more

Stay in Touch

There are many ways you can keep up on the latest health tips, news and events from Lenox Hill Hospital.

Read our E-Magazine Read our E-Magazine
 
Receive our E-Newsletters Receive our E-Newsletters
 
Become our Fan on Facebook Become our Fan
 
Follow us on Twitter Follow Us
Bookmark and Share

Online Health Library


Drug treatments: Other drug therapies

Although used less frequently than other cholesterol-lowering medications, there are times when other drug treatments, such as fibrates, may be appropriate.

Fibrates

The cholesterol-lowering drugs called fibrates are primarily effective in lowering triglycerides and, to a lesser extent, increasing HDL (good) cholesterol levels.

Medications in this class include fenofibrate (Antara, Lofibra, Tricor, Triglide) and gemfibrozil.

Fibrates are generally not considered first- or even second-choice drugs for lowering cholesterol, because they are not very effective at lowering LDL cholesterol. They are used when help is needed to bring down triglycerides, often in combination with other cholesterol-lowering medications that do lower LDL cholesterol.

Fibrates have been shown to lower triglycerides by 20 -50% and to increase HDL cholesterol by 10 - 15%.

The most common side effects include gastrointestinal symptoms (including stomach pain, diarrhea, nausea, vomiting, and constipation) and an increased risk of developing gallstones.

Fibrates can increase the effect of medications that thin the blood (such as warfarin). Your health care provider should monitor this closely, as well as your liver function, which may be affected by fibrates.

When fibrates are taken together with statins (another cholesterol-lowering medication), there is an increased risk of muscle tissue breakdown and kidney failure. The safety and effectiveness of fibrates in children is not known.


Review Date: 12/20/2010
Reviewed By: Norma Keller, MD, Assistant Professor, Cardiac and Vascular Institute, NYU Langone Medical Center, New York, NY. Review provided by VeriMed Healthcare Network. Previously reviewed by Larry A. Weinrauch, MD, Asst. Prof. of Med., Harvard Medical School, and Private practice specializing in Cardiovascular Disease, Watertown, MA. Review provided by VeriMed Healthcare Network (10/10/2008).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com